Syntone Ventures LLC
CIK 1814394 · last filed 2024-04-17
Syntone Ventures LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for OTLK, was dated Apr 17, 2024. Across all open-market trades the lifetime net is +$4.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.25M
2
3
$4.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OTLK | 10%+ Owner | 1,705,438 | $1.32 | $2.25M | $0 | 1 | 2024-04-17 |
| Outlook Therapeutics, Inc. (OTLKW) Delisted | 10%+ Owner | 19,823,045 | $0.03 | $594.7K | $4.00M | 2 | 2021-02-04 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-17 | OTLK | Buy (P) | +714,286 | $0 | EDGAR |
| 2021-02-04 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Buy (P) | +3,000,000 | $3.00M | EDGAR |
| 2020-07-28 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Buy (P) | +823,045 | $1000.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.